Solid Biosciences (SLDB) Stock Chart & Stock Price History $4.02 -0.44 (-9.87%) (As of 03:46 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Solid Biosciences Stock Price Performance 5 Day Performance-9.37%1 Month Performance-11.00%3 Month Performance-37.68%6 Month Performance-34.56%Year-To-Date Performance-27.52%1 Year Performance-9.92% Receive SLDB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Solid Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover SLDB Stock Chart for Wednesday, December, 18, 2024 SLDB Chart by TradingView Solid Biosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$4.60$4.46-3.04%$4.74$4.36398,605 shs$178.20 million12/16/2024$4.91$4.60-6.31%$4.94$4.60323,936 shs$183.82 million12/13/2024$4.68$4.91+4.91%$4.97$4.67465,509 shs$196.20 million12/12/2024$5.01$4.68-6.59%$5.10$4.67227,143 shs$187.01 million12/11/2024$5.05$5.01-0.79%$5.13$4.78186,672 shs$200.20 million12/10/2024$5.11$5.05-1.17%$5.19$5.01193,147 shs$201.80 million Get the Latest News and Ratings for SLDB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Solid Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$5.05$5.11+1.19%$5.40$5.02211,777 shs$204.20 million12/06/2024$4.96$5.05+1.81%$5.16$4.96194,772 shs$201.80 million12/05/2024$5.18$4.96-4.25%$5.30$4.82379,331 shs$198.20 million12/04/2024$5.18$5.18$5.29$5.01306,369 shs$206.97 million12/03/2024$5.79$5.18-10.54%$5.72$5.17307,872 shs$206.99 million12/02/2024$5.70$5.79+1.58%$5.84$5.64112,450 shs$231.37 million11/29/2024$5.69$5.70+0.18%$5.78$5.5962,337 shs$227.77 million11/28/2024$5.69$5.69$5.89$5.6595,013 shs$227.37 million11/27/2024$5.78$5.69-1.56%$5.89$5.6594,799 shs$227.37 million11/26/2024$5.86$5.78-1.37%$6.00$5.69237,622 shs$230.97 million11/25/2024$5.41$5.86+8.32%$6.11$5.40565,207 shs$234.17 million11/22/2024$5.23$5.41+3.44%$5.62$5.21403,537 shs$216.16 million11/21/2024$4.96$5.23+5.44%$5.38$4.94458,294 shs$208.99 million11/20/2024$5.11$4.96-2.94%$5.10$4.90376,820 shs$198.20 million11/19/2024$5.00$5.11+2.20%$5.19$4.75575,728 shs$204.20 million11/18/2024$4.85$5.00+3.09%$5.11$4.61567,840 shs$199.78 million Related Companies Erasca Stock Chart Cronos Group Stock Chart Evolus Stock Chart Dianthus Therapeutics Stock Chart Rapport Therapeutics Stock Chart Autolus Therapeutics Stock Chart Oculis Stock Chart Cullinan Therapeutics Stock Chart Arbutus Biopharma Stock Chart Entrada Therapeutics Stock Chart Receive SLDB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Solid Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SLDB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
